Sort
40,608 grants matching “prostate cancer”
Personalized Risk-AdaptIve Surveillance (PRAISE) - Implications of Algorithmic Bias
$423,669Aasthaa Bansal · University Of Washington · R37 · FY2024 · CA
A Novel "Zinc-Stapled" Long-Acting Insulin Analog
$423,635Bruce Hill Frank · Thermalin Diabetes, Llc · R43 · FY2010 · DK
Structure, function, and application of novel antagonists of the intrinsically disordered androgen receptor amino-terminal domain as imaging agents and therapeutics
$423,596Marianne D Sadar · Provincial Health Services Authority · R01 · FY2024 · CA
Radiobioeffect Modeling of αRPT
$423,590George Sgouros · Johns Hopkins University · P01 · FY2024 · CA
Community Outreach and Engagement
$423,531Ken A. Resnicow · University Of Michigan At Ann Arbor · P30 · FY2023 · CA
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters
$423,523Avner Schlessinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
$423,501Dean G Tang · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Dissecting the immunological mechanisms associated with prostate cancer progression in African-American men and exploring epigenetics-based immune modulation for therapy
$423,486Dennis O Adeegbe · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2021 · CA
Preventing Melanoma Metastasis by Targeting Lipid Vulnerabilities in Lymph
$423,468Jessalyn Ubellacker · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · CA
Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma
$423,458David Paul Turner · Virginia Commonwealth University · R01 · FY2025 · CA
Genetics of Prostate Cancer Risk & Agressiveness
$423,354Graham Casey · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · CA
Targeted MRI contrast agents for differential diagnosis of prostate cancer
$423,352Zheng-Rong Lu · Case Western Reserve University · R01 · FY2017 · CA
Role of TbRIII in Regulating Motility and Invasion
$423,323Gerard C Blobe · Duke University · R01 · FY2012 · CA
Informed Decision Making Regarding PSA Screening
$423,306University Of California Los Angeles · R01 · FY2004 · CA
Statistical Methods for Prospective Evaluation of Biomarkers
$423,294Yingye Zheng · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Cross-sectional and prospective cohort data analysis of physical activity and hea
$423,292Paul T Williams · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2010 · HL
TARGET-GUIDED DEVELOPMENT OF SPECIFIC AKT INHIBITORS
$423,289Peter K Vogt · Scripps Research Institute, The · R01 · FY2008 · CA
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER
$423,276University Of Colorado Denver · N01 · FY2000 · CN
OSTEOPOROTIC FRACTURES IN MEN (MR.OS)
$423,253Oregon Health And Science University · U01 · FY2004 · AR
GENETIC EPIDEMIOLOGY OF PROSTATE CANCER
$423,218Fred Hutchinson Cancer Research Center · R01 · FY2002 · CA
3D SONOELASTOGRAPHY IMAGING FOR PROSTATE CANCER
$423,178Deborah J. Rubens · University Of Rochester · R01 · FY2006 · AG
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
$423,130Asmaa Elkenawi · Indiana University Indianapolis · R21 · FY2023 · CA
Defining therapeutic strategies for boosting T-cell infiltration into cold tumors with spatial proteomics and machine learning
$423,078Matthew W. Thomson · California Institute Of Technology · R21 · FY2023 · CA
PathCAM: connecting the digital data pipeline in diagnostic pathology with onboard-camera variable resolution slide imaging
$423,047Jonathan Quincy Brown · Tulane University Of Louisiana · R01 · FY2023 · GM
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy
$422,964Zhiguo Li · University Of Kentucky · R01 · FY2024 · CA